Pentobarbital capabilities throughout the CNS by binding to gamma-aminobutyric acid (GABA) A subtype receptors. This motion potentiates GABA effects, leading to CNS depression and inhibiting glutamate, even further resulting in an additive effect on CNS depression. Even though the deficiency of an antidote has led to reduced first-line use in the d